Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cromolyn Sodium and Cetirizine in CP/CPPS
NCT03167216Phase 1Completed
- Sponsor
- Northwestern University
- Start
- Aug 2017
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sodium cromoglycate and cetirizine in chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS), sponsored by Northwestern University. Primary endpoint: Mast cell tryptase levels in expressed prostatic secretions at 3 weeks. Started Aug 2017; status: completed.
02
Drugs
sodium cromoglycatecetirizine
03
Conditions
chronic prostatitis (CP)chronic pelvic pain syndrome (CPPS)
Beyond the preview
Go deeper on NCT03167216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03167216.